Seoriel

Seoriel is a South Korean biotechnology company focused on developing innovative therapies for metabolic and degenerative diseases by targeting mitochondrial dysfunction. The company utilizes a proprietary platform to identify small molecules that can modulate mitochondrial activity and cellular metabolism to treat conditions such as sarcopenia and nonalcoholic steatohepatitis (NASH/MASH). Seoriel's research emphasizes the restoration of muscle function and the improvement of metabolic health in aging populations. By addressing the underlying mechanisms of mitochondrial decay, the company aims to provide first-in-class treatments for high-unmet-need indications including obesity and type 2 diabetes.